WHO ICTRP trial
Investigation of systemic microvascular dysfunction in heart failure with…
NL-OMON23162 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON23162 |
|---|---|
| Public title | Investigation of systemic microvascular dysfunction in heart failure with preserved ejection fraction in males and females |
| Scientific title | Prospective Case-Control Study to Evaluate Systemic Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction in Males and Females (PROSE-HFpEF) |
| Primary sponsor | Academisch ziekenhuis Maastricht |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational non invasive |
| Conditions | Heart Failure with preserved Ejection Fraction (HFpEF) ;10019280 |
| Interventions | Niet van toepassing. Observationele studie zonder interventie. ;Other intervention |
| Registration date | Apr 10, 2019 |
| Target size | 1850 |
| Secondary IDs | NL7655;NL 68796.068.19 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: